News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yakup Ergün: A great article discussing the optimal use of PARP inhibitors by Valentina Tuninetti
Ovarian Cancer
Nov 18, 2024, 09:53

Yakup Ergün: A great article discussing the optimal use of PARP inhibitors by Valentina Tuninetti

Yakup Ergün, Medical Oncologist at Bower Hospital, shared an article by V. Tuninetti, Oncologist at Mauriziano Hospital in Turin, on X:

” A great article discussing the optimal use of PARP inhibitors, their re-use after progression, and the relationship between their duration of use and the incidence of hematological malignancies.“

Yakup Ergün: A great article discussing the optimal use of PARP inhibitors by Valentina Tuninetti

Long-term outcomes of PARP inhibitors in ovarian cancer: survival, adverse events, and post-progression insights.

Authors: V. Tuninetti, et al.

Yakup Ergün: A great article discussing the optimal use of PARP inhibitors by Valentina Tuninetti

Bower Hospital cancer hematological malignancies Mauriziano Hospital OncoDaily Oncology PARP inhibitors Valentina Tuninetti Yakup Ergün
Special Coverage
Oncolibrary
Aug 4, 2025, 04:12
Lung Cancer Chemotherapy Success Rate: What Patients Need to Know in 2025
Radiotherapy
Aug 4, 2025, 01:19
Varian: Radiotherapy Giant
Blog
Aug 3, 2025, 20:47
Debanjan Kundu: I am Privileged to Have Visited This Centuries-Old Hospital as an AROI WB Young Oncology Fellow
Insight
Aug 3, 2025, 20:42
Armando Orlandi։ Redefining Who Should Consider Preventive Breast Surgery
Blog
Aug 3, 2025, 20:29
Al-Ola A Abdallah: 2nd Regional ‪2025 Immune Cell Effector Therapy Symposium Conference
Blog
Aug 3, 2025, 20:04
How the Latest Evidence Is Used in EGFR-Mutated NSCLC Treatment - NCODA
Blog
Aug 3, 2025, 19:45
Miguel Bronchud: Primary Tumor Surgery Lymphadenectomy?
Blog
Aug 3, 2025, 19:41
Hung Trinh: First-of-its-kind Clinical Trial - Reprogramming Stem Cells to Create Renewable Cancer-fighting T Cells
Insight
Aug 3, 2025, 19:32
Amol Akhade: Understanding the Hidden Rules of Trial Design
Blog
Aug 3, 2025, 19:26
Dewi Vernerey: The Results of the ASTER 70s Trial
Insight
Aug 3, 2025, 19:25
Patrick Hwu։ Why Do Some Gastrointestinal Cancers Become Resistant to KRAS-targeted Therapies?
Insight
Aug 3, 2025, 19:18
Wafaa M Rashed: Polygenic Risk Score for Cancer in African Population